Please try another search
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Zhixiang Sun | 55 | 2021 | Independent Non-Executive Director |
Jonathan H. Chou | 59 | 2021 | Independent Non-Executive Director |
Luying Yan | 41 | 2020 | VP & Executive Director |
Junjie Zhang | 45 | 2019 | Non-Executive Director |
Jiandong Ding | 58 | 2021 | Independent Non-Executive Director |
Liang Zhao | 43 | 2022 | Executive Director & First VP of Total Solutions |
Xia Wu | 41 | 2019 | Non-Executive Director |
Guoming Chen | 38 | 2020 | Non-Executive Chairman of the Board |
Jeffrey R Lindstrom | 57 | 2023 | President, GM & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review